Mounjaro®
Starting from £179.99/mo
Start journey Learn moreIn the UK private market, 12.5 mg Mounjaro is typically priced somewhere in the range of £149 to £375 per four-week pen, varying by provider and dose — figures that reflect the significant list-price increase Eli Lilly introduced on 1 September 2025. That headline number, though, rarely tells the whole story. Whether the cost of 12.5 mg Mounjaro represents value depends almost entirely on what sits alongside it: clinical assessment, a valid prescription, and support if something goes wrong. Mounjaro is a prescription-only medicine, which means a qualified prescriber must assess your suitability before any treatment can be supplied — and that assessment is part of what you are paying for, even when a provider buries it in the price.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The short answer is that providers are not all selling the same thing. Eli Lilly supplies Mounjaro through the licensed UK supply chain, so the medicine itself is the same pen regardless of where you buy it. What differs is everything wrapped around it.
Some providers quote a price that covers the pen only. The consultation, the prescription fee, and any aftercare support are billed separately, or quietly not offered at all. Others bundle everything into a single figure. When you compare two listings for 12.5 mg Mounjaro cost and one looks noticeably lower, it is almost always because something has been stripped out rather than because the medicine is genuinely cheaper to source.
Since September 2025, Eli Lilly's UK list price for the higher-dose pens rose sharply, as widely reported, the highest doses moved from around £122 to around £330 per pen at list. Private providers have adjusted accordingly, which is why prices you may have seen a year ago no longer reflect the market. The range now runs roughly £149 to £375 per month depending on dose and provider, and the Mounjaro 12.5 mg price sits toward the higher end of that range by dose. These figures are quoted from widely reported market coverage and should be treated as indicative rather than fixed.
You can read more about the broader picture of Mounjaro pricing across all doses, or look specifically at the questions people ask most about the cost of 12.5 mg Mounjaro.
This is the question worth asking before you commit to any provider, and the answer comes up more than you might expect. A common misconception is that all online pharmacies offering Mounjaro operate in roughly the same way. In practice, the differences in what is included matter considerably, particularly at a dose like 12.5 mg, where you are further into a titration schedule and clinical oversight becomes more rather than less important.
Items frequently excluded from headline prices include: the initial consultation fee, the prescription charge, aftercare or dose-review support between orders, and delivery costs. Some providers charge for each of these separately; others offer aftercare as a paid add-on. A few do not offer it at all.
There is also the question of what happens if you experience side effects. Gastrointestinal effects (nausea, loose stools, indigestion) are common as doses increase, and knowing there is a prescriber you can contact without paying again is a practical consideration, not a luxury. The Mounjaro treatment overview covers what to expect through titration and why clinical support at this stage matters.
For context on how the 12.5 mg pricing compares to earlier dose costs, the page on 2.5 mg Mounjaro cost shows how much the price structure has shifted from the starter dose upward.
nume is not the cheapest provider for Mounjaro. That is a deliberate position rather than an oversight. The single price includes the consultation, the prescription, the medicine, next-working-day tracked DPD delivery in plain packaging, and prescriber aftercare seven days a week. There is no subscription, and every repeat order is clinically re-reviewed before dispatch rather than processed automatically. Pricing is shown transparently on the treatment page.
If you are searching for the cheapest 12.5 mg Mounjaro, the lowest listed price you find may well be genuine. But for a prescription medicine at this dose, the right question is not which provider costs least, it is which provider includes the clinical oversight that 12.5 mg actually requires. Dose increases need evidence; repeat orders need review; the prescriber who approved your first pen should be accountable for subsequent ones too.
The MHRA has issued clear warnings about counterfeit weight-loss pens sold online and via social media, including fake pens that have contained insulin. Any seller offering Mounjaro without a clinical assessment, or at prices far below the current market range, is a red flag worth taking seriously. You can verify any online pharmacy on the GPhC register, and report suspect sellers at yellowcard.mhra.gov.uk. Safety, not price, is the right measure for a prescription medicine. If you have questions about how much Mounjaro is in Northern Ireland, where availability and pricing can differ from the rest of the UK, that page covers the specifics. If you have questions about how the process works, the FAQs page covers the most common ones.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.